{"id":"W2114743668","doi":"10.1161/atvbaha.114.303396","title":"Clinical Experience With the New Oral Anticoagulants for Treatment of Venous Thromboembolism","year":2014,"lang":"en","type":"review","venue":"Arteriosclerosis Thrombosis and Vascular Biology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Edoxaban; Dabigatran; Rivaroxaban; Apixaban; Vitamin K antagonist; Venous thromboembolism; Clinical trial; Intensive care medicine; Atrial fibrillation; Heparin; Warfarin; Anesthesia; Internal medicine; Thrombosis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01130798,0.0003764327,0.001114252,0.0009265239,0.0002238925,0.001221538,0.0006561023,0.0007307443,0.002874751],"category_scores_gemma":[0.02094215,0.0002494498,0.001220044,0.002538353,0.0006185073,0.001465014,0.0007194192,0.00170187,0.0006224888],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007764579,"about_ca_system_score_gemma":0.001147504,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007550152,"about_ca_topic_score_gemma":0.001101565,"domain_scores_codex":[0.9937325,0.00294869,0.001102727,0.0007001442,0.001408711,0.0001071602],"domain_scores_gemma":[0.9791654,0.01319901,0.002968038,0.000719682,0.003203392,0.0007445538],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00208424,0.0002583031,0.01726647,0.02075116,0.003204794,0.0004888054,0.0008358181,0.0006080468,0.002462254,0.002942646,0.02673834,0.9223592],"study_design_scores_gemma":[0.001396721,0.005806175,0.0643016,0.02084015,0.005982743,0.01093244,0.00098017,0.0004335352,0.003596117,0.003212458,0.8823627,0.0001552048],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.006535756,0.9865444,0.0004903346,0.002637356,0.0004035653,0.00002150466,0.00008894192,0.000007204043,0.003270911],"genre_scores_gemma":[0.0522097,0.9390092,0.001501027,0.003968359,0.001670822,0.00005555915,0.0002812076,0.00001812149,0.001286043],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.01130798,"threshold_uncertainty_score":0.05980307,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1432435831962288,"score_gpt":0.424970045518583,"score_spread":0.2817264623223542,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}